WithdrawnPhase 3NCT02527213
Double-blind Trial of Sodium Thiosulfate for the Treatment of Pain Associated With Calcific Uremic Arteriolopathy
Studying Calciphylaxis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- American Regent, Inc.
- Principal Investigator
- Linda Mundy, MD, PhDAmerican Regent, Inc.
- Intervention
- Sodium thiosulfate(drug)
- Eligibility
- 18 years · All sexes
- Timeline
- 2015 – 2016
Study locations (3)
- Nephrology Consultants, Huntsville, Alabama, United States
- Nephrology Association of Northern Indiana, Fort Wayne, Indiana, United States
- A.A. Northeast Clinical Research Center, Bethlehem, Pennsylvania, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02527213 on ClinicalTrials.govOther trials for Calciphylaxis
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07511283Calciphylaxis in Patients With Chronic Kidney Disease - A Study of the Danish Calciphylaxis Research Initiative (DanCaRI)Odense University Hospital
- RECRUITINGNANCT04654000Rheopheresis as Adjuvant Treatment of CalciphylaxisUniversity Hospital, Lille
- RECRUITINGPHASE3NCT05018221Better Evidence and Translation for CalciphylaxisUniversity of Sydney
- RECRUITINGEARLY PHASE1NCT04592640Human Amniotic-Derived Mesenchymal Stem Cell Therapy for CalciphylaxisThe First Affiliated Hospital with Nanjing Medical University
- RECRUITINGNCT03032835Partners Calciphylaxis BiobankMassachusetts General Hospital
- RECRUITINGNCT02280733A Real-World Registry of Chronic Wounds and UlcersU.S. Wound Registry